Why are autoimmune and inflammatory diseases still so difficult to treat?🔬
The Immunology and Inflammation therapeutic area is one of the most active and rapidly evolving fields in modern drug development, shifting from broad immunosuppression toward increasingly targeted immunomodulation and biomarker-informed approaches.
🔑 Key Clinical Focus Areas and Priorities
🩻 Rheumatology & Gastroenterology ➡️ Rheumatoid arthritis and IBD, including Crohn’s disease and ulcerative colitis.
🧫 Immuno-Dermatology & Nephrology ➡️ Atopic dermatitis, psoriasis, IgA nephropathy and lupus nephritis.
🧬 Translational Research ➡️ Biomarker identification for patient stratification and treatment-response prediction.
Autoimmune diseases alone are estimated to affect up to 10% of the global population — representing hundreds of millions of people worldwide. Across Europe, clinical research activity normalized per million people shows notable regional variation, with particularly high relative activity in Northern Europe. Yet many of these conditions remain challenging to diagnose, predict, and treat effectively.
What can make this therapeutic area challenging?
🔬 Complex disease biology ➡️ Genetic, environmental, and immune factors create highly diverse disease profiles.
🧩 Patient heterogeneity ➡️ Differences in disease severity, biomarkers, and treatment response make patient selection challenging.
📊 Measuring treatment response ➡️ Fluctuating disease activity can complicate endpoint selection and the assessment of meaningful treatment response.
🌍 Recruitment challenges ➡️ Restrictive eligibility criteria, complex study requirements, and high screen-failure rates can make the recruitment of suitable patients challenging..
💡 As research moves toward more targeted and personalized approaches, high-quality clinical trial execution is essential to translate scientific advances into better treatment options.
At BiTrial, we actively support clinical research in the Autoimmune & Inflammation therapeutic area, helping sponsors navigate patient recruitment, study operations and clinical development across our international network.
🤝 Looking for a reliable CRO partner? Contact us!